ORKA
Price
$8.91
Change
-$0.51 (-5.41%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
333.97M
RLFTY
Price
$3.00
Change
+$0.20 (+7.14%)
Updated
Apr 1 closing price
Capitalization
32.07M
Ad is loading...

ORKA vs RLFTY

Header iconORKA vs RLFTY Comparison
Open Charts ORKA vs RLFTYBanner chart's image
Oruka Therapeutics
Price$8.91
Change-$0.51 (-5.41%)
Volume$5.61K
Capitalization333.97M
RELIEF THERAPEUTICS HLDG AG
Price$3.00
Change+$0.20 (+7.14%)
Volume$225
Capitalization32.07M
ORKA vs RLFTY Comparison Chart
Loading...
ORKA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORKA vs. RLFTY commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORKA is a Buy and RLFTY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ORKA: $8.92 vs. RLFTY: $2.49)
Brand notoriety: ORKA and RLFTY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORKA: 107% vs. RLFTY: 150%
Market capitalization -- ORKA: $333.97M vs. RLFTY: $32.07M
ORKA [@Biotechnology] is valued at $333.97M. RLFTY’s [@Biotechnology] market capitalization is $32.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORKA’s FA Score shows that 1 FA rating(s) are green whileRLFTY’s FA Score has 1 green FA rating(s).

  • ORKA’s FA Score: 1 green, 4 red.
  • RLFTY’s FA Score: 1 green, 4 red.
According to our system of comparison, ORKA is a better buy in the long-term than RLFTY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORKA’s TA Score shows that 4 TA indicator(s) are bullish.

  • ORKA’s TA Score: 4 bullish, 6 bearish.

Price Growth

ORKA (@Biotechnology) experienced а -25.36% price change this week, while RLFTY (@Biotechnology) price change was -9.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

ORKA is expected to report earnings on Nov 13, 2024.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORKA($334M) has a higher market cap than RLFTY($32.1M). RLFTY YTD gains are higher at: -49.184 vs. ORKA (-53.997). ORKA has more cash in the bank: 411M vs. RLFTY (10.7M). ORKA has less debt than RLFTY: ORKA (988K) vs RLFTY (2.42M).
ORKARLFTYORKA / RLFTY
Capitalization334M32.1M1,040%
EBITDAN/A-48.16M-
Gain YTD-53.997-49.184110%
P/E RatioN/AN/A-
RevenueN/A8.59M-
Total Cash411M10.7M3,841%
Total Debt988K2.42M41%
FUNDAMENTALS RATINGS
ORKA: Fundamental Ratings
ORKA
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ORKA
RSI
ODDS (%)
Bullish Trend 3 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 7 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
58%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
ORKA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IBTM23.080.24
+1.05%
iShares iBonds Dec 2032 Term Trs ETF
XNAV65.79N/A
N/A
FundX Aggressive ETF
FDEC42.24-1.52
-3.47%
FT Vest US Equity Buffer ETF Dec
DWUS44.79-2.41
-5.11%
AdvisorShares DW FSM US Core ETF
VOOG321.43-18.67
-5.49%
Vanguard S&P 500 Growth ETF

ORKA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORKA has been loosely correlated with PCVX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORKA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORKA
1D Price
Change %
ORKA100%
-5.31%
PCVX - ORKA
44%
Loosely correlated
-9.35%
RLFTF - ORKA
31%
Poorly correlated
+2.14%
RLFTY - ORKA
24%
Poorly correlated
-17.00%
CMMB - ORKA
22%
Poorly correlated
-4.77%
ENTX - ORKA
22%
Poorly correlated
-2.38%
More

RLFTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLFTY has been loosely correlated with RLFTF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RLFTY jumps, then RLFTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLFTY
1D Price
Change %
RLFTY100%
-17.00%
RLFTF - RLFTY
43%
Loosely correlated
+2.14%
ORKA - RLFTY
23%
Poorly correlated
-5.31%
PCVX - RLFTY
21%
Poorly correlated
-9.35%
HOTH - RLFTY
21%
Poorly correlated
-4.13%
NERV - RLFTY
21%
Poorly correlated
-4.35%
More